Skip to content
Start Your Quest
Uncategorized

How to Develop a Psychiatric Treatment Plan Using DSM-5-TR

6 min read

Some NRNP 6635 evaluations, and most later PMHNP courses, ask you to move from diagnosis to treatment. A strong psychiatric treatment plan flows directly from the DSM-5-TR diagnosis, current guidelines and the patient’s goals and circumstances. This guide explains how to develop a psychiatric treatment plan using the DSM-5-TR diagnosis as your foundation.

Quick answer

Start with a clearly specified DSM-5-TR diagnosis and comorbidities, set SMART patient-centered goals, select evidence-based pharmacologic and psychotherapeutic treatment, address safety and level of care, order baseline labs and monitoring, educate the patient and family, address social determinants and schedule follow-up with measurement-based care.

1. Start With a Specific Diagnosis

Use the full DSM-5-TR name with specifiers, such as “major depressive disorder, single episode, moderate, with anxious distress” (American Psychiatric Association, 2022). Specifiers guide treatment; for example, psychotic features or mixed features change medication choices.

2. Set Patient-Centered SMART Goals

Example goals

Within 8 weeks, the patient will report a 50% reduction in PHQ-9 score; within 2 weeks, the patient will sleep at least 6 hours on most nights; within 4 weeks, the patient will return to work part time.

3. Choose Evidence-Based Treatment

DiagnosisGuideline-supported first-line options (examples)Source
Major depressive disorderPsychotherapy (CBT, IPT, behavioral activation) and/or SSRI, SNRI, bupropion or mirtazapineVA/DoD (2022)
Bipolar I, acute maniaLithium, quetiapine, divalproex, asenapine, aripiprazole, paliperidone, risperidone, cariprazineYatham et al. (2018)
SchizophreniaAntipsychotic medication plus psychosocial interventions; clozapine for treatment resistanceKeepers et al. (2020)
Generalized anxiety disorderCBT and/or SSRI or SNRISzuhany & Simon (2022)
PTSDTrauma-focused psychotherapy (PE, CPT, EMDR); sertraline, paroxetine or venlafaxineVA/DoD (2023)

Choose specific agents based on side effects, comorbidities, drug interactions, prior response, cost, pregnancy potential and patient preference. A psychopharmacology reference such as Stahl (2021) helps explain mechanism and dosing rationale.

4. Address Safety and Level of Care

Document suicide and violence risk, the safety plan, means restriction counseling and whether outpatient, intensive outpatient, partial hospitalization or inpatient care is appropriate.

5. Order Labs and Plan Monitoring

Examples include metabolic monitoring for antipsychotics; lithium levels, renal and thyroid function; liver function and CBC for valproate; ECG when QTc risk is relevant; and pregnancy testing when appropriate.

6. Use Measurement-Based Care

Repeat validated rating scales, such as the PHQ-9, GAD-7 or PCL-5, at follow-up visits to guide adjustments. Measurement-based care improves outcomes compared with usual care and is underused in practice (Fortney et al., 2017).

7. Educate and Address Social Needs

Explain the diagnosis, expected benefits and side effects, time to response and warning signs. Address barriers such as cost, transportation and support; see social determinants of health in psychiatric patient evaluations.

8. Schedule Follow-Up

Specify timing, such as 2–4 weeks after starting an antidepressant, and what will be reassessed.

Frequently Asked Questions

Should every plan include both medication and therapy?

Not always. Choose based on diagnosis, severity, guidelines and patient preference; for some conditions, psychotherapy alone is first-line.

How specific should medication recommendations be?

Name the drug, starting dose, titration plan and monitoring, with rationale and citations, if your assignment requires prescribing detail.

What is measurement-based care?

Using validated rating scales at regular intervals to track symptoms and guide treatment decisions.

Get Help Building Your Treatment Plan at Collepals

Comprehensive psychiatric evaluations take time, and NRNP 6635 often requires a new one every few weeks. Collepals.com supports PMHNP students with:

  • Guidance on organizing your case into the comprehensive psychiatric evaluation template.
  • Help comparing DSM-5-TR criteria and building three well-supported differential diagnoses.
  • Current, evidence-based references formatted in APA 7.
  • Model evaluations, case presentations and reflections you can study, plus editing and proofreading of your drafts.

Browse our free model assignments or learn more about our nursing assignment writing service.

Get NRNP 6635 help at Collepals.com

Use Collepals examples as study guides and follow your university’s academic integrity and AI policies when you submit your own work.

More NRNP 6635 study guides

  • NRNP 6635 Comprehensive Psychiatric Evaluation: Complete Guide
  • How to Develop Three Differential Diagnoses in Psychiatric Evaluations
  • NRNP 6635 Major Depressive Disorder Case Study
  • NRNP 6635 Bipolar Disorder Psychiatric Evaluation
  • NRNP 6635 Schizophrenia and Psychotic Disorders Case Study
  • NRNP 6635 PTSD Psychiatric Evaluation

Collepals is an independent study resource and is not affiliated with or endorsed by Walden University. Course requirements, templates and rubrics change; always follow your current syllabus and course template. This article is educational and is not clinical advice for any individual patient.

References

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787

Fortney, J. C., Unützer, J., Wrenn, G., Pyne, J. M., Smith, G. R., Schoenbaum, M., & Harbin, H. T. (2017). A tipping point for measurement-based care. Psychiatric Services, 68(2), 179–188. https://doi.org/10.1176/appi.ps.201500439

Keepers, G. A., Fochtmann, L. J., Anzia, J. M., Benjamin, S., Lyness, J. M., Mojtabai, R., Servis, M., Walaszek, A., Buckley, P., Lenzenweger, M. F., Young, A. S., Degenhardt, A., & Hong, S.-H. (2020). The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry, 177(9), 868–872. https://doi.org/10.1176/appi.ajp.2020.177901

Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press.

Szuhany, K. L., & Simon, N. M. (2022). Anxiety disorders: A review. JAMA, 328(24), 2431–2445. https://doi.org/10.1001/jama.2022.22744

U.S. Department of Veterans Affairs & U.S. Department of Defense. (2022). VA/DoD clinical practice guideline for the management of major depressive disorder (Version 4.0). https://www.healthquality.va.gov/guidelines/MH/mdd/

U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder (Version 4.0). https://www.healthquality.va.gov/guidelines/MH/ptsd/

Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., Alda, M., MacQueen, G., Milev, R. V., Ravindran, A., O’Donovan, C., McIntosh, D., Lam, R. W., Vazquez, G., Kapczinski, F., … Berk, M. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders, 20(2), 97–170. https://doi.org/10.1111/bdi.12609

Academic Writer & Editor
WhatsApp